Abstract:The continuous emergence of multidrug‐resistant bacterial pathogens poses a major global healthcare challenge, with Klebsiella pneumoniae being a prominent threat. We conducted a comprehensive study on K. pneumoniae's antibiotic resistance mechanisms, focusing on outer membrane vesicles (OMVs) and polymyxin, a last‐resort antibiotic. Our research demonstrates that OMVs protect bacteria from polymyxins. OMVs derived from Polymyxin B (PB)‐stressed K. pneumoniae exhibited heightened protective efficacy due to increased vesiculation, compared to OMVs from unstressed Klebsiella. OMVs also shield bacteria from different bacterial families. This was validated ex vivo and in vivo using precision cut lung slices (PCLS) and Galleria mellonella. In all models, OMVs protected K. pneumoniae from PB and reduced the associated stress response on protein level. We observed significant changes in the lipid composition of OMVs upon PB treatment, affecting their binding capacity to PB. The altered binding capacity of single OMVs from PB stressed K. pneumoniae could be linked to a reduction in the lipid A amount of their released vesicles. Although the amount of lipid A per vesicle is reduced, the overall increase in the number of vesicles results in an increased protection because the sum of lipid A and therefore PB binding sites have increased. This unravels the mechanism of the altered PB protective efficacy of OMVs from PB stressed K. pneumoniae compared to control OMVs. The lipid A‐dependent protective effect against PB was confirmed in vitro using artificial vesicles. Moreover, artificial vesicles successfully protected Klebsiella from PB ex vivo and in vivo. The findings indicate that OMVs act as protective shields for bacteria by binding to polymyxins, effectively serving as decoys and preventing antibiotic interaction with the cell surface. Our findings provide valuable insights into the mechanisms underlying antibiotic cross‐protection and offer potential avenues for the development of novel therapeutic interventions to address the escalating threat of multidrug‐resistant bacterial infections.

Outer Membrane Vesicles Protect Gram-Negative Bacteria against Host Defense Peptides

Gelatin emulsion gels loaded with host defence peptides for the treatment of antibiotic-resistant infections

Combating bacterial infections with host defense peptides: Shifting focus from bacteria to host immunity

Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria

Host defense peptides mitigate the spread of antibiotic resistance in physiologically relevant condition

Bacterial resistance mechanisms against host defense peptides

Sustainable deployment of host defense peptides for targeted quorum sensing inhibition

Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria

Lipid A in outer membrane vesicles shields bacteria from polymyxins

Regulation of the Intestinal Barrier Function by Host Defense Peptides.

Host Defense Peptide Mimicking Cyclic Peptoid Polymers Exerting Strong Activity Against Drug-Resistant Bacteria

Understanding the Dynamics of Human Defensin Antimicrobial Peptides: Pathogen Resistance and Commensal Induction

Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria

The Discovery of the Role of Outer Membrane Vesicles against Bacteria

Lipidated Α/α-Aa Heterogeneous Peptides As Antimicrobial Agents.

Outer Membrane Vesicles (OMVs) as Biomedical Tools and Their Relevance as Immune-Modulating Agents against H. pylori Infections: Current Status and Future Prospects

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

Outer Membrane Vesicle Production by Escherichia coli Enhances Its Defense against Phage Infection

Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens

Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases

Gram-Negative Bacteria’s Outer Membrane Vesicles